PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+16.19%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.01B
AUM Growth
+$2.01B
(+21%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
42.09%
Holding
88
New
23
Increased
17
Reduced
15
Closed
3
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$34.6M |
| 2 |
Zimmer Biomet
ZBH
|
$24.8M |
| 3 |
DexCom
DXCM
|
$21.6M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$20.8M |
| 5 |
West Pharmaceutical
WST
|
$20.3M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$41.2M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$17.1M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$15.7M |
| 4 |
Roivant Sciences
ROIV
|
$13.6M |
| 5 |
Sana Biotechnology
SANA
|
$12.1M |
Sector Composition
| 1 | Healthcare | 95.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Align Technology
ALGN
$10.3B
| $7.46M | 0.35% | +22,751 | New | +$7.46M |
|
52
Inspire Medical Systems
INSP
$2.77B
| $7.21M | 0.34% | +33,557 | New | +$7.21M |
|
|
ITCI
53
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.84M | 0.32% | +98,879 | New | +$6.84M |
|
|
54
Sana Biotechnology
SANA
$777M
| $6.75M | 0.32% | 675,000 -1,208,337 | -64% | -$12.1M |
|
55
Generation Bio
GBIO
$40.4M
| $6.6M | 0.31% | 1,622,487 | – | – |
|
56
Xenon Pharmaceuticals
XENE
$2.98B
| $6.48M | 0.3% | 150,554 -42,302 | -22% | -$1.82M |
|
|
SILK
57
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.07M | 0.29% | +331,064 | New | +$6.07M |
|
|
58
Day One Biopharmaceuticals
DAWN
$769M
| $5.87M | 0.28% | 355,251 -948,324 | -73% | -$15.7M |
|
59
Erasca
ERAS
$445M
| $5.22M | 0.25% | 2,535,102 -40,409 | -2% | -$83.2K |
|
60
Apellis Pharmaceuticals
APLS
$3.48B
| $4.88M | 0.23% | +82,952 | New | +$4.88M |
|
61
Iovance Biotherapeutics
IOVA
$807M
| $4.61M | 0.22% | +310,754 | New | +$4.61M |
|
62
Astria Therapeutics
ATXS
$349M
| $4.6M | 0.22% | +327,045 | New | +$4.6M |
|
63
Cullinan Oncology
CGEM
$445M
| $4.36M | 0.21% | +255,967 | New | +$4.36M |
|
64
Sagimet Biosciences
SGMT
$244M
| $4.35M | 0.2% | 802,712 +126,259 | +19% | +$684K |
|
65
IO Biotech
IOBT
$104M
| $4.05M | 0.19% | 2,341,107 | – | – |
|
|
CNTA
66
Centessa Pharmaceuticals
CNTA
$2.25B
| $3.56M | 0.17% | +314,674 | New | +$3.56M |
|
67
EyePoint Pharmaceuticals
EYPT
$797M
| $3.53M | 0.17% | 170,871 | – | – |
|
68
iShares China Large-Cap ETF
FXI
$6.65B
| $3.4M | 0.16% | +141,122 | New | +$3.4M |
|
69
Viking Therapeutics
VKTX
$3.04B
| $2.69M | 0.13% | +32,827 | New | +$2.69M |
|
|
BLUE
70
DELISTED
bluebird bio
BLUE
| $2.61M | 0.12% | 2,042,651 | – | – |
|
71
Outset Medical
OM
$247M
| $2.59M | 0.12% | 1,168,035 +168,776 | +17% | +$375K |
|
|
TSBX
72
DELISTED
Turnstone Biologics
TSBX
| $2.41M | 0.11% | 920,976 +287,663 | +45% | +$754K |
|
73
PMV Pharmaceuticals
PMVP
$74.2M
| $2.17M | 0.1% | 1,275,462 -197,551 | -13% | -$336K |
|
|
BOLD
74
Boundless Bio
BOLD
$25.1M
| $2M | 0.09% | +140,513 | New | +$2M |
|
|
INBX
75
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.68M | 0.08% | 47,918 -490,046 | -91% | -$17.1M |
|